| |
| |
|
| Insider
Information: |
Ajer Jeffrey Robert |
| Relationship: |
Director |
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
100,920 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,960,934 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
100,920 |
|
|
| Total
Value |
$5,960,934 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -80.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Commercial ... |
2024-05-02 |
66,767 |
|
0 |
Premium* |
|
|
Nektar Therapeutics |
NKTR |
Director |
2023-09-18 |
34,153 |
2017-09-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
174 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2017-05-02 |
4 |
AS |
$96.74 |
$29,215 |
D/D |
(302) |
51,532 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2017-05-05 |
4 |
AS |
$99.00 |
$444,114 |
D/D |
(4,486) |
51,532 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2017-05-05 |
4 |
OE |
$28.23 |
$162,879 |
D/D |
4,486 |
55,030 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2017-05-15 |
4 |
D |
$91.50 |
$100,284 |
D/D |
(1,096) |
50,436 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2017-06-02 |
4 |
D |
$90.72 |
$134,991 |
D/D |
(1,488) |
48,948 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2017-06-07 |
4 |
AS |
$89.61 |
$89,968 |
D/D |
(1,004) |
47,944 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2017-09-19 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
22,500 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2017-09-22 |
4 |
AS |
$95.00 |
$334,495 |
D/D |
(3,521) |
47,944 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2017-09-22 |
4 |
OE |
$37.46 |
$131,897 |
D/D |
3,521 |
50,110 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
12,529 |
59,918 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-02-26 |
4/A |
A |
$0.00 |
$0 |
D/D |
12,615 |
60,004 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-03-02 |
4 |
D |
$79.86 |
$128,894 |
D/D |
(1,614) |
58,304 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-03-09 |
4 |
AS |
$82.39 |
$244,863 |
D/D |
(2,972) |
55,332 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
12,840 |
64,521 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-03-15 |
4 |
D |
$83.57 |
$305,114 |
D/D |
(3,651) |
51,681 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-03-21 |
4 |
AS |
$83.90 |
$366,475 |
D/D |
(4,368) |
60,153 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-03-22 |
4/A |
D |
$81.36 |
$292,733 |
D/D |
(3,598) |
56,555 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-03-22 |
4 |
D |
$81.36 |
$291,513 |
D/D |
(3,583) |
56,570 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-03-29 |
4 |
AS |
$79.69 |
$122,484 |
D/D |
(1,537) |
55,033 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-04-02 |
4 |
AS |
$80.12 |
$169,774 |
D/D |
(2,119) |
52,914 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-04-30 |
4 |
A |
$68.78 |
$21,254 |
D/D |
309 |
53,223 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-05-07 |
4 |
AS |
$85.96 |
$26,562 |
D/D |
(309) |
52,914 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-06-04 |
4 |
D |
$92.07 |
$130,187 |
D/D |
(1,414) |
51,571 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-06-11 |
4 |
AS |
$90.31 |
$129,685 |
D/D |
(1,436) |
50,135 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-09-20 |
4 |
AS |
$56.76 |
$383,130 |
D/D |
(6,750) |
15,750 |
0 |
- |
|
174 Records found
|
|
Page 4 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
